apotechnos limited Company Information
Company Number
09290866
Next Accounts
Mar 2025
Shareholders
enertechnos holdings limited
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
Registered Address
19 kingsmill business park, chapel mill road, kingston-upon-thames, surrey, KT1 3GZ
Website
http://enertechnos.comapotechnos limited Estimated Valuation
Pomanda estimates the enterprise value of APOTECHNOS LIMITED at £0 based on a Turnover of £0 and 1.28x industry multiple (adjusted for size and gross margin).
apotechnos limited Estimated Valuation
Pomanda estimates the enterprise value of APOTECHNOS LIMITED at £90.1k based on an EBITDA of £15.4k and a 5.86x industry multiple (adjusted for size and gross margin).
apotechnos limited Estimated Valuation
Pomanda estimates the enterprise value of APOTECHNOS LIMITED at £0 based on Net Assets of £-15.9k and 2.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Apotechnos Limited Overview
Apotechnos Limited is a live company located in kingston-upon-thames, KT1 3GZ with a Companies House number of 09290866. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in October 2014, it's largest shareholder is enertechnos holdings limited with a 100% stake. Apotechnos Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Apotechnos Limited Health Check
There is insufficient data available to calculate a health check for Apotechnos Limited. Company Health Check FAQs


0 Strong

0 Regular

2 Weak

Size
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Growth
There is insufficient data available for this Key Performance Indicator!
- Apotechnos Limited
- - Industry AVG

Production
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Profitability
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Employees
with 2 employees, this is below the industry average (42)
- - Apotechnos Limited
- - Industry AVG

Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Apotechnos Limited
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 318.4%, this is a higher level of debt than the average (44.4%)
- - Apotechnos Limited
- - Industry AVG
APOTECHNOS LIMITED financials

Apotechnos Limited's latest turnover from June 2023 is 0 and the company has net assets of -£15.9 thousand. According to their latest financial statements, Apotechnos Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||
Other Income Or Grants | |||||||||
Cost Of Sales | |||||||||
Gross Profit | |||||||||
Admin Expenses | |||||||||
Operating Profit | 15,367 | ||||||||
Interest Payable | |||||||||
Interest Receivable | |||||||||
Pre-Tax Profit | 15,367 | ||||||||
Tax | |||||||||
Profit After Tax | 15,367 | ||||||||
Dividends Paid | |||||||||
Retained Profit | 15,367 | ||||||||
Employee Costs | |||||||||
Number Of Employees | 2 | ||||||||
EBITDA* | 15,367 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | |
---|---|---|---|---|---|---|---|---|---|
Tangible Assets | |||||||||
Intangible Assets | 7,288 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
Investments & Other | |||||||||
Debtors (Due After 1 year) | |||||||||
Total Fixed Assets | 7,288 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
Stock & work in progress | |||||||||
Trade Debtors | |||||||||
Group Debtors | |||||||||
Misc Debtors | |||||||||
Cash | 1 | 1 | |||||||
misc current assets | |||||||||
total current assets | 1 | 1 | |||||||
total assets | 7,288 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,001 | 5,001 |
Bank overdraft | |||||||||
Bank loan | |||||||||
Trade Creditors | 14,455 | 5,000 | |||||||
Group/Directors Accounts | 22,701 | 35,267 | 35,267 | 35,267 | 35,267 | 30,864 | 22,141 | ||
other short term finances | |||||||||
hp & lease commitments | |||||||||
other current liabilities | 500 | 1,013 | 1,013 | 1,013 | 1,013 | 1,776 | 763 | ||
total current liabilities | 23,201 | 36,280 | 36,280 | 36,280 | 36,280 | 32,640 | 22,904 | 14,455 | 5,000 |
loans | |||||||||
hp & lease commitments | |||||||||
Accruals and Deferred Income | |||||||||
other liabilities | |||||||||
provisions | |||||||||
total long term liabilities | |||||||||
total liabilities | 23,201 | 36,280 | 36,280 | 36,280 | 36,280 | 32,640 | 22,904 | 14,455 | 5,000 |
net assets | -15,913 | -31,280 | -31,280 | -31,280 | -31,280 | -27,640 | -17,904 | -9,454 | 1 |
total shareholders funds | -15,913 | -31,280 | -31,280 | -31,280 | -31,280 | -27,640 | -17,904 | -9,454 | 1 |
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||
Operating Profit | 15,367 | ||||||||
Depreciation | |||||||||
Amortisation | |||||||||
Tax | |||||||||
Stock | |||||||||
Debtors | |||||||||
Creditors | -14,455 | 9,455 | 5,000 | ||||||
Accruals and Deferred Income | -513 | -763 | 1,013 | 763 | |||||
Deferred Taxes & Provisions | |||||||||
Cash flow from operations | |||||||||
Investing Activities | |||||||||
capital expenditure | |||||||||
Change in Investments | |||||||||
cash flow from investments | |||||||||
Financing Activities | |||||||||
Bank loans | |||||||||
Group/Directors Accounts | -12,566 | 4,403 | 8,723 | 22,141 | |||||
Other Short Term Loans | |||||||||
Long term loans | |||||||||
Hire Purchase and Lease Commitments | |||||||||
other long term liabilities | |||||||||
share issue | |||||||||
interest | |||||||||
cash flow from financing | -12,566 | ||||||||
cash and cash equivalents | |||||||||
cash | -1 | 1 | |||||||
overdraft | |||||||||
change in cash | -1 | 1 |
apotechnos limited Credit Report and Business Information
Apotechnos Limited Competitor Analysis

Perform a competitor analysis for apotechnos limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in KT1 area or any other competitors across 12 key performance metrics.
apotechnos limited Ownership
APOTECHNOS LIMITED group structure
Apotechnos Limited has no subsidiary companies.
apotechnos limited directors
Apotechnos Limited currently has 2 directors. The longest serving directors include Mr Dominic Quennell (Oct 2014) and Mr Gareth O'Brien (Oct 2014).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Dominic Quennell | 68 years | Oct 2014 | - | Director | |
Mr Gareth O'Brien | 53 years | Oct 2014 | - | Director |
P&L
June 2023turnover
0
0%
operating profit
15.4k
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
-15.9k
-0.49%
total assets
7.3k
+0.46%
cash
0
0%
net assets
Total assets minus all liabilities
apotechnos limited company details
company number
09290866
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
October 2014
age
11
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
June 2023
previous names
N/A
accountant
-
auditor
-
address
19 kingsmill business park, chapel mill road, kingston-upon-thames, surrey, KT1 3GZ
Bank
-
Legal Advisor
-
apotechnos limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to apotechnos limited.
apotechnos limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for APOTECHNOS LIMITED. This can take several minutes, an email will notify you when this has completed.
apotechnos limited Companies House Filings - See Documents
date | description | view/download |
---|